{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:33:17Z","timestamp":1768339997695,"version":"3.49.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1093\/jac\/dkx018","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T08:23:51Z","timestamp":1485764631000},"page":"1745-1751","source":"Crossref","is-referenced-by-count":11,"title":["Switch as maintenance to elvitegravir\/cobicistat\/emtricitabine\/tenofovir disoproxil fumarate: week 48 results in a clinical cohort"],"prefix":"10.1093","volume":"72","author":[{"given":"Marine","family":"Perrier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Blondel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Visseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Matheron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Landman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"key\n\t\t\t\t20170519061956_dkx018-B1","doi-asserted-by":"crossref","first-page":"19805","DOI":"10.7448\/IAS.17.4.19805","article-title":"Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis","volume":"17","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B2","doi-asserted-by":"crossref","first-page":"19793","DOI":"10.7448\/IAS.17.4.19793","article-title":"Switch to Stribild versus continuation of NVP or RPV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-NNRTI subgroup analysis","volume":"17","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B3","doi-asserted-by":"crossref","first-page":"e113876","DOI":"10.1371\/journal.pone.0113876","article-title":"Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3851\/IMP2093","article-title":"Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients","volume":"17","year":"2012","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/QAD.0b013e3283427de3","article-title":"Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy\/ml","volume":"25","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jmv.21405","article-title":"Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation","volume":"81","year":"2009","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/bmc.865","article-title":"Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry","volume":"21","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/jac\/dkv425","article-title":"Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B9"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1310\/hct1502-51","article-title":"Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate\/emtricitabine to once-daily elvitegravir\/cobicistat\/emtricitabine\/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks data","volume":"15","year":"2014","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B11","doi-asserted-by":"crossref","first-page":"e0134430","DOI":"10.1371\/journal.pone.0134430","article-title":"Use of PCR signal and therapeutic drug monitoring in a switch cohort study to tenofovir\/emtricitabine\/rilpivirine: a W96 follow-up","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2011.01.022","article-title":"Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence","volume":"57","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170519061956_dkx018-B13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QAI.0b013e3182645648","article-title":"Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function","volume":"61","year":"2012","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/6\/1745\/17234795\/dkx018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:00:24Z","timestamp":1568761224000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,2,10]]},"published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx018","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}